Effectiveness of a Third Dose of BNT162b2 mRNA Vaccine

Journal of Infectious Diseases
Volume 225, Issue 1, 1 January 2022
https://academic.oup.com/jid/issue/225/1

 

MAJOR ARTICLES AND BRIEF REPORTS
Effectiveness of a Third Dose of BNT162b2 mRNA Vaccine
Yaki Saciuk, Jennifer Kertes, Naama Shamir Stein, Anat Ekka Zohar
The Journal of Infectious Diseases, Volume 225, Issue 1, 1 January 2022, Pages 30–33, https://doi.org/10.1093/infdis/jiab556
Providing a third dose of BNT152b2 6 months after the first 2 doses evidenced a vaccine effectiveness against infection rate of 89%. The reduction in infection risk 2 months after the third-dose vaccination campaign reinforces the wisdom of its implementation.